Contact: Ralph Barry, Chief Business Officer, Aegis Therapeutics LLC
1-858-618-1400 Ext. 102, Email: rbarry@aegisthera.com

Yearly Archives: 2007

Aegis Therapeutics to Present at the “C21 BioVentures Conference” in Monterey California in May 2007

SAN DIEGO, CA April 4, 2007/MarketWire/– Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will present its recently formed Cedar Therapeutics Inc. spin-out company at the C21 Bioventures Conference to be held at the Monterey Plaza Hotel and Spa, Monterey, CA  May 22-24, 2007.  Cedar Therapeutics was formed to […]

Aegis Therapeutics to Present Intravail® and ProTek® Technologies at the “Drug Delivery 2007 Conference” in San Francisco on April 10, 2007

SAN DIEGO, CA April 3, 2007/MarketWire/– Aegis Therapeutics, a leader in intranasal drug delivery, will present a talk entitled: “High-Efficiency Delivery of Peptides, Proteins, and Other Macromolecules via Intranasal & Other Transmucosal Routes” at the Arrowhead “Drug Delivery 2007 Conference”.  The conference will be held on April 10, 2007 at the Crown Plaza Union Square, […]

Aegis Therapeutics To Introduce Its Cedar Therapeutics Inc. Spin-out Company at the Frost and Sullivan Venture Connections 2007 Symposium in San Francisco

SAN DIEGO, CA March 1, 2007/MarketWire/– Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will introduce its recently formed Cedar Therapeutics Inc. spin-out company at the Frost and Sullivan Venture Connections 2007 Executive Symposium on March 14, 2007.  Cedar Therapeutics was formed to develop novel, proprietary, and superior formulations […]